When it was passed in 1992, no one thought to mandate how hospitals and clinics would spend the deep discounts they receive on prescription drugs.

Report finds hospitals price the same cancer drugs up to 2000x apart, worsening financial toxicity and intensifying demands for real transparency.

Using nationally representative data, the authors found that for common physician-administered drugs, hospitals’ unilaterally set cash prices are frequently lower than their median—and sometimes even ...

Experts examine MFN pricing, the Great Healthcare Plan, ACA subsidies, PBM reform, and CMS talks in 2026. Lindsay Bealor ...

Leerink Global Healthcare Conference 2026 March 10, 2026 9:20 AM EDTCompany ParticipantsPablo Cagnoni - President and Head ...

The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...

Join Health Affairs Publishing on Monday, March 30, 2026, for a virtual event featuring Kristi Martin of Highway 136 ...

The bills will establish an advisory panel to examine data and ensure that federal drug pricing caps are applied to state-regulated health insurance plans if signed into law.

Key Takeaways The Missouri AG filed suit in St. Louis County Circuit Court against several PBMs and drug manufacturers, alleging they conspired to manipulate Missouri’s health care market and ...

Thousands of low-income people living with HIV could be losing drug coverage as states impose limitations on HIV assistance programs amid constrained budgets — raising alarms over consistent ...

An amendment to a bill on drug costs adds $31 million to restore eligibility to people in the AIDS Drug Assistance Program, ...